Express News | Watching SpringWorks Therapeutics; Shares Trading Higher, Traders Circulate M&A Blog Comments Suggesting The Co Has Received Takeover Speculation
SpringWorks Therapeutics Rumor Highlighted in Betaville Alert
SpringWorks Therapeutics Price Target Lowered to $78 From $80 at Guggenheim
SpringWorks Therapeutics Price Target Cut to $78.00/Share From $80.00 by Guggenheim
Guggenheim Initiates SpringWorks Therapeutics(SWTX.US) With Buy Rating, Announces Target Price $78
BofA Securities Maintains SpringWorks Therapeutics(SWTX.US) With Buy Rating, Cuts Target Price to $55
